John L Higgins insider trades

Open-market stock purchases and sales by John L Higgins, Director at BIO-TECHNE Corp, from SEC Form 4 filings since Feb 23, 2008.

Track record: 80% of 10 scored buys are up 5% or more since purchase, averaging +131%.

Recent trades

DateStockTradeValue
Sep 28, 2026TECH BIO-TECHNE CorpBought (not open market)—
Sep 28, 2026TECH BIO-TECHNE CorpSold (not open market)$403K
Sep 28, 2026TECH BIO-TECHNE CorpBought (not open market)—
Jun 17, 2026OABI OmniAb, IncBought (not open market)—
Jun 17, 2026OABI OmniAb, IncBought (not open market)—
Jun 17, 2026OABI OmniAb, IncBought (not open market)—
Jan 30, 2026OABI OmniAb, IncBought (not open market)—
Nov 7, 2025OABI OmniAb, IncBought$56.6K
Nov 6, 2025OABI OmniAb, IncBought$51.1K
Oct 30, 2025TECH BIO-TECHNE CorpBought (not open market)—
Oct 30, 2025TECH BIO-TECHNE CorpBought (not open market)—

Companies traded

  • TECH BIO-TECHNE Corp: 15 sales, last Sep 28, 2026
  • OABI OmniAb, Inc: 5 buys, 3 sales, last Jun 17, 2026
  • LGND Ligand Pharmaceuticals Inc: 10 buys, 37 sales, last Dec 28, 2022
  • BCRX Biocryst Pharmaceuticals Inc: other filings, last May 23, 2012
  • LGNDD Ligand Pharmaceuticals Inc: other filings, last Feb 9, 2012

Get free alerts when John L Higgins files a new trade →